We have some knowledge of PP2A role in CML and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) thanks in large part to the work of the Perrotti group in their studies on BCR–ABL regulation of PP2A in these diseases (18–23). This evidence concerns the gene PTPA and chronic myelogenous leukemia, BCR-ABL1 positive.